Enoticumab (Anti-DLL4)
Enoticumab (Anti-DLL4) is a human monoclonal antibody directed against Delta-like ligand-4 (DLL4) with potential antineoplastic activity.It has been used to treat advanced solid tumors MW : 146.48 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2848 |
| Sku # | A2848-1mg*5 |
| Pricing | 1mg*5, $1690.00 |